QBFM
SGMO

QS Batterymarch Financial Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

QS Batterymarch Financial Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.73M Sell
160,519
-16,640
-9% -$217K 0.05% 440
2014
Q2 		$2.71M Buy
177,159
+163,859
+1,232% +$2.36M 0.07% 386
2014
Q1 		$241K Hold
13,300
– – 0.01% 841
2013
Q4 		$185K Hold
13,300
– – ﹤0.01% 900
2013
Q3 		$140K Hold
13,300
– – ﹤0.01% 937
2013
Q2 		$104K Buy
+13,300
New +$116K ﹤0.01% 976

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

QS Batterymarch Financial Management's SGMO Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 9.4% in Q3 2014, selling an estimated $217K and leaving 160,519 shares worth $1.73M. The position accounts for 0.05% of the portfolio, ranked #440.

QS Batterymarch Financial Management first reported a position in SGMO in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.71M in Q2 2014. 157 funds tracked by Wall St. Rank hold SGMO as of Q3 2014.

  • QS Batterymarch Financial Management held 160,519 shares of SANGAMO THERAPEUTICS INC worth $1.73M as of Q3 2014.
  • QS Batterymarch Financial Management sold 16,640 SANGAMO THERAPEUTICS INC shares in Q3 2014, an estimated $217K.
  • SANGAMO THERAPEUTICS INC made up 0.05% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #440 holding.
  • QS Batterymarch Financial Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 6 quarters since.
  • QS Batterymarch Financial Management's SANGAMO THERAPEUTICS INC position peaked at $2.71M in Q2 2014.
  • 157 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.